AbbVie Inc. Insider Trading

ABBV

Last 12 months

Insiders sold $18.9M and bought nothing on the open market.

50% of the selling was scheduled in advance under 10b5-1 plans. EVP, Chief Bus/strat Officer Nicholas Donoghoe sold $8.18M on Aug 14, 31% of their stake, outside a plan. The last open-market buy by an executive or director was in Mar 2020.

Net open-market

−$18.9M

0 buys · 4 sales

Under a 10b5-1 plan

50%

of the value sold

Insiders who bought / sold

0 / 3

executives and directors

Last open-market buy

Mar 2020

Mar 20, 2020

Get an email when ABBV's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 14	Nicholas Donoghoe EVP, Chief Bus/strat Officer	SoldNo plan	32,710	$250.00	$8.18M	31%	Form 4
Mar 4	David Ryan Purdue SVP, Controller	SoldNo plan	5,230	$233.56	$1.22M	66%	Form 4
Mar 2	Perry C Siatis EVP, GC and Secretary	Sold10b5-1 plan 3 parts	18,668	$234.39 average	$4.38M	80%	Form 4
Feb 25	Perry C Siatis EVP, GC and Secretary	Sold10b5-1 plan	22,381	$230.00	$5.15M	37%	Form 4
Aug 12, 2025	Azita Saleki-Gerhardt EVP, Chief Operations Officer	SoldNo plan	42,370	$198.42	$8.41M	19%	Form 4
Aug 5, 2025	Nicholas Donoghoe EVP, Chief Bus/strat Officer	SoldNo plan 2 parts	13,295	$198.51 average	$2.64M	19%	Form 4
Mar 31, 2025	Jeffrey Ryan Stewart EVP, Chief Commercial Officer	SoldNo plan 2 parts	58,832	$210.08 average	$12.4M	52%	Form 4
Mar 14, 2025	Scott T Reents EVP, Chief Financial Officer	SoldNo plan	17,644	$212.34	$3.75M	60%	Form 4
Mar 3, 2025	Timothy J. Richmond EVP, Chief Hr Officer	Sold10b5-1 plan 3 parts	21,250	$210.45 average	$4.47M	78%	Form 4
Feb 28, 2025 – Mar 3, 2025	Richard A Gonzalez Director	SoldNo plan 2 parts	98,628	$205.45 average	$20.3M	20%	Form 4
Feb 28, 2025 – Mar 3, 2025	Perry C Siatis EVP, GC and Secretary	Sold10b5-1 plan 4 parts	27,900	$208.69 average	$5.82M	86%	Form 4
Feb 26, 2025	Kevin K Buckbee SVP, Controller	SoldNo plan 2 parts	18,944	$203.41 average	$3.85M	62%	Form 4
Feb 26, 2025	Timothy J. Richmond EVP, Chief Hr Officer	Sold10b5-1 plan 6 parts	29,917	$202.90 average	$6.07M	40%	Form 4
Feb 20, 2025	Perry C Siatis EVP, GC and Secretary	Sold10b5-1 plan 2 parts	5,778	$197.90 average	$1.14M	21%	Form 4
Dec 16, 2024	Kevin K Buckbee SVP, Controller	SoldNo plan	1,800	$172.24	310K	20%	Form 4

Aug 14No plan
Nicholas Donoghoe
EVP, Chief Bus/strat Officer · sold 32,710 at $250.00
$8.18M
31% of stake
Mar 4No plan
David Ryan Purdue
SVP, Controller · sold 5,230 at $233.56
$1.22M
66% of stake
Mar 210b5-1 plan
Perry C Siatis
EVP, GC and Secretary · sold 18,668 at avg $234.39
$4.38M
80% of stake
Feb 2510b5-1 plan
Perry C Siatis
EVP, GC and Secretary · sold 22,381 at $230.00
$5.15M
37% of stake
Aug 12, 2025No plan
Azita Saleki-Gerhardt
EVP, Chief Operations Officer · sold 42,370 at $198.42
$8.41M
19% of stake
Aug 5, 2025No plan
Nicholas Donoghoe
EVP, Chief Bus/strat Officer · sold 13,295 at avg $198.51
$2.64M
19% of stake
Mar 31, 2025No plan
Jeffrey Ryan Stewart
EVP, Chief Commercial Officer · sold 58,832 at avg $210.08
$12.4M
52% of stake
Mar 14, 2025No plan
Scott T Reents
EVP, Chief Financial Officer · sold 17,644 at $212.34
$3.75M
60% of stake
Mar 3, 202510b5-1 plan
Timothy J. Richmond
EVP, Chief Hr Officer · sold 21,250 at avg $210.45
$4.47M
78% of stake
Feb 28, 2025 – Mar 3, 2025No plan
Richard A Gonzalez
Director · sold 98,628 at avg $205.45
$20.3M
20% of stake
Feb 28, 2025 – Mar 3, 202510b5-1 plan
Perry C Siatis
EVP, GC and Secretary · sold 27,900 at avg $208.69
$5.82M
86% of stake
Feb 26, 2025No plan
Kevin K Buckbee
SVP, Controller · sold 18,944 at avg $203.41
$3.85M
62% of stake
Feb 26, 202510b5-1 plan
Timothy J. Richmond
EVP, Chief Hr Officer · sold 29,917 at avg $202.90
$6.07M
40% of stake
Feb 20, 202510b5-1 plan
Perry C Siatis
EVP, GC and Secretary · sold 5,778 at avg $197.90
$1.14M
21% of stake
Dec 16, 2024No plan
Kevin K Buckbee
SVP, Controller · sold 1,800 at $172.24
310K
20% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ABBV, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with ABBV

CompareIntrinsic value

MRKMerck & Co., Inc.

$150.36+3.93%41

PFEPfizer Inc.

$30.79+2.63%30

BMYBristol-Myers Squibb Company

$64.20+4.04%61

LLYEli Lilly and Company

$1,418.07+0.62%73

ABTAbbott Laboratories

$115.55+5.62%25

JNJJohnson & Johnson

$276.34+3.82%53

UPCUniverse Pharmaceuticals Inc.

$1.47-1.34%39

TEVATeva Pharmaceutical Industries Ltd

$42.13+0.52%46

Held by ETFs

ABBV is in 460 US ETFs. The largest of them, with ABBV's weight in each:

Spot a number that looks wrong? Check it in ABBV's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ABBV

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.